REPORT ID 3794

EMEA (Europe, Middle East and Africa) Liver Cancer Diagnostic Tests Market Report 2017

Publish Date
14-Dec-17
Pages
108
Format
Electronic (PDF)

In this report, the EMEA Liver Cancer Diagnostic Tests market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Liver Cancer Diagnostic Tests for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Liver Cancer Diagnostic Tests market competition by top manufacturers/players, with Liver Cancer Diagnostic Tests sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott Diagnostics
    Abcodia
    BioMark Technologies
    AXO Science SAS
    Bioprognos SL
    China Sky One Medica
    Digna Biotech SL
    Glycotest

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Reagent
    Instrument

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Physical Examination Center
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Liver Cancer Diagnostic Tests Market Report 2017
1 Liver Cancer Diagnostic Tests Overview
    1.1 Product Overview and Scope of Liver Cancer Diagnostic Tests
    1.2 Classification of Liver Cancer Diagnostic Tests
        1.2.1 EMEA Liver Cancer Diagnostic Tests Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Liver Cancer Diagnostic Tests Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Reagent
        1.2.4 Instrument
    1.3 EMEA Liver Cancer Diagnostic Tests Market by Application/End Users
        1.3.1 EMEA Liver Cancer Diagnostic Tests Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Physical Examination Center
        1.3.4 Other
    1.4 EMEA Liver Cancer Diagnostic Tests Market by Region
        1.4.1 EMEA Liver Cancer Diagnostic Tests Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Liver Cancer Diagnostic Tests (2012-2022)
        1.5.1 EMEA Liver Cancer Diagnostic Tests Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Liver Cancer Diagnostic Tests Revenue and Growth Rate (2012-2022)

2 EMEA Liver Cancer Diagnostic Tests Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Liver Cancer Diagnostic Tests Market Competition by Players/Manufacturers
        2.1.1 EMEA Liver Cancer Diagnostic Tests Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Liver Cancer Diagnostic Tests Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Liver Cancer Diagnostic Tests Sale Price by Players (2012-2017)
    2.2 EMEA Liver Cancer Diagnostic Tests (Volume and Value) by Type/Product Category
        2.2.1 EMEA Liver Cancer Diagnostic Tests Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Liver Cancer Diagnostic Tests Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Liver Cancer Diagnostic Tests Sale Price by Type (2012-2017)
    2.3 EMEA Liver Cancer Diagnostic Tests (Volume) by Application
    2.4 EMEA Liver Cancer Diagnostic Tests (Volume and Value) by Region
        2.4.1 EMEA Liver Cancer Diagnostic Tests Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Liver Cancer Diagnostic Tests Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Liver Cancer Diagnostic Tests Sales Price by Region (2012-2017)

3 Europe Liver Cancer Diagnostic Tests (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Liver Cancer Diagnostic Tests Sales and Value (2012-2017)
        3.1.1 Europe Liver Cancer Diagnostic Tests Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Liver Cancer Diagnostic Tests Revenue and Growth Rate (2012-2017)
    3.2 Europe Liver Cancer Diagnostic Tests Sales and Market Share by Type
    3.3 Europe Liver Cancer Diagnostic Tests Sales and Market Share by Application
    3.4 Europe Liver Cancer Diagnostic Tests Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Liver Cancer Diagnostic Tests Sales Volume by Countries (2012-2017)
        3.4.2 Europe Liver Cancer Diagnostic Tests Revenue by Countries (2012-2017)
        3.4.3 Germany Liver Cancer Diagnostic Tests Sales and Growth Rate (2012-2017)
        3.4.4 France Liver Cancer Diagnostic Tests Sales and Growth Rate (2012-2017)
        3.4.5 UK Liver Cancer Diagnostic Tests Sales and Growth Rate (2012-2017)
        3.4.6 Russia Liver Cancer Diagnostic Tests Sales and Growth Rate (2012-2017)
        3.4.7 Italy Liver Cancer Diagnostic Tests Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Liver Cancer Diagnostic Tests Sales and Growth Rate (2012-2017)

4 Middle East Liver Cancer Diagnostic Tests (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Liver Cancer Diagnostic Tests Sales and Value (2012-2017)
        4.1.1 Middle East Liver Cancer Diagnostic Tests Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Liver Cancer Diagnostic Tests Revenue and Growth Rate (2012-2017)
    4.2 Middle East Liver Cancer Diagnostic Tests Sales and Market Share by Type
    4.3 Middle East Liver Cancer Diagnostic Tests Sales and Market Share by Application
    4.4 Middle East Liver Cancer Diagnostic Tests Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Liver Cancer Diagnostic Tests Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Liver Cancer Diagnostic Tests Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Liver Cancer Diagnostic Tests Sales and Growth Rate (2012-2017)
        4.4.4 Israel Liver Cancer Diagnostic Tests Sales and Growth Rate (2012-2017)
        4.4.5 UAE Liver Cancer Diagnostic Tests Sales and Growth Rate (2012-2017)
        4.4.6 Iran Liver Cancer Diagnostic Tests Sales and Growth Rate (2012-2017)

5 Africa Liver Cancer Diagnostic Tests (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Liver Cancer Diagnostic Tests Sales and Value (2012-2017)
        5.1.1 Africa Liver Cancer Diagnostic Tests Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Liver Cancer Diagnostic Tests Revenue and Growth Rate (2012-2017)
    5.2 Africa Liver Cancer Diagnostic Tests Sales and Market Share by Type
    5.3 Africa Liver Cancer Diagnostic Tests Sales and Market Share by Application
    5.4 Africa Liver Cancer Diagnostic Tests Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Liver Cancer Diagnostic Tests Sales Volume by Countries (2012-2017)
        5.4.2 Africa Liver Cancer Diagnostic Tests Revenue by Countries (2012-2017)
        5.4.3 South Africa Liver Cancer Diagnostic Tests Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Liver Cancer Diagnostic Tests Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Liver Cancer Diagnostic Tests Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Liver Cancer Diagnostic Tests Sales and Growth Rate (2012-2017)

6 EMEA Liver Cancer Diagnostic Tests Manufacturers/Players Profiles and Sales Data
    6.1 Abbott Diagnostics
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Liver Cancer Diagnostic Tests Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Abbott Diagnostics Liver Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Abcodia
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Liver Cancer Diagnostic Tests Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Abcodia Liver Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 BioMark Technologies
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Liver Cancer Diagnostic Tests Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 BioMark Technologies Liver Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 AXO Science SAS
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Liver Cancer Diagnostic Tests Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 AXO Science SAS Liver Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Bioprognos SL
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Liver Cancer Diagnostic Tests Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Bioprognos SL Liver Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 China Sky One Medica
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Liver Cancer Diagnostic Tests Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 China Sky One Medica Liver Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Digna Biotech SL
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Liver Cancer Diagnostic Tests Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Digna Biotech SL Liver Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Glycotest
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Liver Cancer Diagnostic Tests Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Glycotest Liver Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview

7 Liver Cancer Diagnostic Tests Manufacturing Cost Analysis
    7.1 Liver Cancer Diagnostic Tests Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Liver Cancer Diagnostic Tests

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Liver Cancer Diagnostic Tests Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Liver Cancer Diagnostic Tests Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Liver Cancer Diagnostic Tests Market Forecast (2017-2022)
    11.1 EMEA Liver Cancer Diagnostic Tests Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Liver Cancer Diagnostic Tests Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Liver Cancer Diagnostic Tests Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Liver Cancer Diagnostic Tests Price and Trend Forecast (2017-2022)
    11.2 EMEA Liver Cancer Diagnostic Tests Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Liver Cancer Diagnostic Tests Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Liver Cancer Diagnostic Tests Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Liver Cancer Diagnostic Tests Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Liver Cancer Diagnostic Tests Sales Forecast by Type (2017-2022)
    11.7 EMEA Liver Cancer Diagnostic Tests Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer